Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal ...
Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development ...
Remuseum’s second report concludes that admission fees are raising few funds and keeping out potential visitors—and ...
Marketing and sales expenses increased by €2.8 million in 2024 compared to 2023, as 2024 represented the first full year of ...
The Company reported a record full-year billed revenue of $32.9M (CAD $47M) in 2024, representing a year-over-year increase of 39% from 2023.The Company recorded its highest-ever quarterly billed reve ...
Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...
The Washington Post on MSN9d
U.N. report accuses Israel of sexual violence, ‘genocidal acts’ in GazaThe attack destroyed about 4,000 cryogenically frozen embryos, along with 1,000 sperm samples and ... taken together, “form ...
The release of our first S-K 1300 report for Tanbreez is a significant milestone for Critical Metals Corp as we are quickly advancing the development strategy for this game-changing rare earth deposit ...
Aiforia Technologies Plc’s Financial Statements Bulletin for January–December 2024 (unaudited): Aiforia’s market position and orderbook strengthened Aiforia arranges a live webcast on a result ...
VANCOUVER, British Columbia, March 12, 2025 (GLOBE NEWSWIRE) -- Fortuna mining Corp. (NYSE: FSM \| TSX: FVI) provides its updated Mineral Reserve a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results